Navigation Links
Sequential R-CHOP and Ibritumomab Tiuxetan (Zevalin(R)) Regimen Produces Impressive Survival Rates in High Risk Elderly Patients With Untreated Aggressive Diffuse Large B-cell Lymphoma
Date:6/8/2008

ent of elderly patients with high risk diffuse large B-cell lymphoma (DLBCL) relapse after treatment with R-CHOP. Treatment options for patients who are ineligible for autologous stem cell transplant are limited. In this analysis, of the 63 patients enrolled on the study, 39 patients had been treated with Zevalin. The median age is 75 years (range 62-86); Karnofsky performance status was <80 percent in 59 percent of patients with a median performance status of 70 percent; prognostic score was high-intermediate/high in 53 percent and 47 percent of patients, respectively. Moderate or high impact comorbidity is present in 86 percent. In the intent-to-treat population, progression-free (PFS) and overall survival (OS) were 59 percent and 65 percent, respectively, at 22 months. In the 39 patients who received Zevalin, PFS and OS were 78 percent and 82 percent, respectively, at 26 months. Responses improved in 11 patients who received Zevalin, with eight patients improving from an unconfirmed (CRu) to a confirmed complete response (CR) and three patients improving from a partial response (PR) to a CR/CRu. The side effects reported included blood count suppression: 26 percent and 36 percent grade 3/4 neutropenia, 15 percent grade 3 anemia, and 36 percent and 31 percent grade 3/4 thrombocytopenia. Six patients had delayed blood count recovery for more than 12 weeks. One patient developed myelodysplasia and two patients died after Zevalin was given, one from a suspected brain hemorrhage and one from congestive heart failure.

About Zevalin(R)

Zevalin(R) (Ibritumomab Tiuxetan) is a form of cancer therapy called radioimmunotherapy and is indicated as part of the Zevalin therapeutic regimen for treatment of relapsed or refractory, low-grade or follicular B-cell non-Hodgkin's lymphoma, including patients with rituximab refractory follicular NHL. It was approved by the FDA in February of 2002 as the first radioimmunotherapeutic agent for the treatment of NHL.

R
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. New Data Offers Insights Into the Potential Role for TYKERB(R) (Lapatinib) in Non-Cytotoxic Chemotherapy-Based Treatment Regimens
2. Perioperative Eloxatin(R)-Based Regimen Significantly Reduced the Risk of Relapse Versus Surgery Alone in Eligible Colorectal Cancer Patients with Initially Resectable Liver Metastases
3. European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection
4. Boehringer Ingelheim Initiates NEwArT Study Comparing Viramune(R) (nevirapine) to a Ritonavir-Boosted Atazanavir-based Regimen in Treatment-Naive HIV Patients
5. Studies Showing Significant Survival Improvement with Taxotere(R)-based Regimens in the Induction Treatment of Patients with Locally Advanced Head and Neck Cancer are Published in the Same Issue of the New England Journal of Medicine
6. Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV
7. New Phase III Data Presented for Once Monthly Dosing Regimen of Risedronate to Treat Postmenopausal Osteoporosis
8. New Study Shows Proprietary Canola Extract, Dermytol(TM), Produces Pronounced Decrease in Malignant Melanoma Tumor Volume
9. Fludarabine, Mitoxantrone and Zevalin(R) Produces 96% Complete Remission Rate in First-Line Treatment of Patients with Follicular Non-Hodgkins Lymphoma
10. Zevalin(R) Combined With High-Dose Chemotherapy and Autologous Stem-Cell Transplantation (ASCT) Produces High Overall Survival and Progression-Free Survival Rates in Patients With Relapsed Non-Hodgkins Lymphoma
11. VELCADE(R) (Bortezomib) for Injection Based Treatment Delivers Impressive Complete Response and Survival in Patients With Newly Diagnosed Multiple Myeloma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... Calif. , Aug. 28, 2015  CytomX Therapeutics, ... treatment of cancer, today announced the filing of a ... and Exchange Commission (SEC) relating to a proposed initial ... shares to be offered and the price range for ... to list its common stock under the symbol "CTMX" ...
(Date:8/28/2015)... DUBLIN , Aug. 28, 2015 ... announced the addition of the "Investigation Report on ... Developed by Roche under the trade name ... in the world. In Feb.26, 2010, it was approved ... injections available in China all ...
(Date:8/28/2015)... 2015  Today, in final recognition of the Centers ... Week, 1-800 Contacts is sharing how to keep lens ... wearers who do not properly care for their lens ... Most contact lens wearers understand the ... lens case is sometimes overlooked.  When proper steps to ...
Breaking Medicine Technology:CytomX Files Registration Statement for Proposed Initial Public Offering 2Investigation Report on China's Bevacizumab Market 2015-2019 21-800 Contacts Shares Tips on How to Clean Lens Cases 2
... 11, 2012 PLC Systems Inc. (OTCBB: PLCSF), a ... it will demonstrate its innovative product, RenalGuard ® , ... of Percutaneous Cardiovascular Interventions (EAPCI).  More than 11,000 clinicians ... to attend this event in Paris, France from May ...
... SOUTH BEND, Ind., May 11, 2012  Heraeus Kulzer, ... announced that it has launched a new light ... Venus Pearl is indicated for adhesively bonded, tooth-colored ... to its remarkably soft consistency, this new universal ...
Cached Medicine Technology:PLC to Demonstrate RenalGuard® at EuroPCR 2012 2PLC to Demonstrate RenalGuard® at EuroPCR 2012 3Heraeus Launches Remarkably Smooth Venus® Pearl Composite 2Heraeus Launches Remarkably Smooth Venus® Pearl Composite 3
(Date:8/29/2015)... ... ... like Toppik , Eau Thermale Avene and Bliss are now available on ... required to qualify for free standard shipping,” said Jennifer Ramirez, the public relations manager. ... the item’s selling price.” , With competitive pricing in the e-commerce market for beauty ...
(Date:8/29/2015)... ... ... popular television program VOICES IN AMERICA, hosted by legendary star of the stage and ... segment to the subject of diabetes. Diabetes is a debilitating health condition that is ... advancements in medical science may prove to be a significant breakthrough that sufferers have ...
(Date:8/28/2015)... ... August 28, 2015 , ... Approximately 2,000 ... Zoo to celebrate children helping children, a thank you to the many creative ... have contributed to the United Methodist initiative to end malaria deaths. , The ...
(Date:8/28/2015)... ... August 28, 2015 , ... ... the FDA’s Position and Best Practices for Compliance, **Presented by FDAnews and ... workshop, chaired by internationally renowned expert Fubin Wu, has been specifically designed ...
(Date:8/28/2015)... ... 28, 2015 , ... Saint Petersburg, FL —Pocket Protein™, a ... carbs, sugar, gluten, lactose or caffeine in a convenient 2 oz. pouch that ... Editor’s Choice Awards. , Five consumer packaged goods (CPG) products were selected by ...
Breaking Medicine News(10 mins):Health News:TheBeautyPlace.com Discounts Shipping on Select Brands 2Health News:Saturday’s United Methodist Event at Columbus Zoo Celebrates Imagine No Malaria 2Health News:Saturday’s United Methodist Event at Columbus Zoo Celebrates Imagine No Malaria 3Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 2Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 3Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 4Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 5Health News:Pocket Protein™ Named 2015 CPG Editor’s Choice Award Finalist by Informa’s SupplySide 2Health News:Pocket Protein™ Named 2015 CPG Editor’s Choice Award Finalist by Informa’s SupplySide 3
... of Leeds have found a mechanism to prevent a ... ,Dr Lezanne Ooi, a postdoctoral researcher in ... progression of cardiac hypertrophy can be halted by increasing ... a significant discovery because whilst the symptoms can be ...
... church of "consequences" if they vote in favour of overturning a ... the ruling Labor Party in the New South Wales state parliament ... how to vote from Sydney Catholic Archbishop George Pell. ... I'm going to do so by saving a lot of lives, ...
... study at Cincinnati Children's Hospital Medical Center, pediatricians now ... with chronic diseases like Crohn's, juvenile arthritis and ... are at increased risk for bone mass deficiencies, fracture ... is a huge demand for this information among clinicians ...
... GAINESVILLE, Fla. University of Florida researchers report the ... cutting the flow of blood .The talc stimulates ... magic bullet for treating metastatic lung cancer. The UF ... for a cancer largely considered incurable. ,Talcum ...
... they are moving closer to understanding why the most ... to drug treatment in the past three decades. They ... in yeast, a protozoan gene that contributes to such ... a two-year period is believed to be the largest ...
... Chinese President Hu Jintao and U.N. Secretary-General Ban Ki-moon ... (G-8) Summit on Thursday, besides giving India's viewpoint ... climate change. ,An External Affairs Ministry background ... of the world's population, it emits only four per ...
Cached Medicine News:Health News:Breakthrough for Treatment of Fatal Heart Condition 2Health News:Australian Catholics Rebel Over Stem Cell Vote Warning 2Health News:A Pratical Tool to Detect Bone Mass Deficiencies in Children With Chronic Diseases 2Health News:A Pratical Tool to Detect Bone Mass Deficiencies in Children With Chronic Diseases 3Health News:A Pratical Tool to Detect Bone Mass Deficiencies in Children With Chronic Diseases 4Health News:Talcum Powder Curbs Lung Tumor Risk 2Health News:Talcum Powder Curbs Lung Tumor Risk 3Health News:New Insights into Antimalarial Drug Resistance 2Health News:New Insights into Antimalarial Drug Resistance 3Health News:New Insights into Antimalarial Drug Resistance 4Health News:Manmohan Singh to Meet UN Chief, Discuss Climate Change 2
Indications For Usage: ,Bypass upper airway obstructions, provide long term ventilation, support and/or manage tracheal/bronchial secretions....
... The permanent flexible tube extension ... the neck flange helps keep ... chin, and stoma, enhancing patient ... ,Bivona® FlexTend™ tracheostomy tubes improve ...
... TTS™ tracheostomy tubes are available in both neonatal ... like an uncuffed tube, but it has a ... the shaft of the tube. , ,TTS™ ... tube with the insurance of a cuff, if ...
Portex® pediatric tracheostomy tubes offer a choice in both form and fit. , ,The anatomical shape of the tube shaft along with the caudal angle of the 15 mm connector provide comfort and security...
Medicine Products: